Antibiotic Susceptibility of NDM-Producing Enterobacterales Collected in the United States in 2017 and 2018 | Zendy

Joseph D. Lutgring | Zendy; Rocío Balbuena | Zendy; Natashia Reese | Zendy; Sarah Gilbert | Zendy; Uzma Ansari | Zendy; Amelia Bhatnagar | Zendy; Sandra Boyd | Zendy; Davina Campbell | Zendy; Jake Cochran | Zendy; Jenn Haynie | Zendy; Justina Ilutsik | Zendy; Cynthia Longo | Zendy; Stephanie Swint | Zendy; J. Kamile Rasheed | Zendy; Allison C. Brown | Zendy; Maria Karlsson | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Antibiotic Susceptibility of NDM-Producing Enterobacterales Collected in the United States in 2017 and 2018

Author(s) -

Joseph D. Lutgring,

Rocío Balbuena,

Natashia Reese,

Sarah Gilbert,

Uzma Ansari,

Amelia Bhatnagar,

Sandra Boyd,

Davina Campbell,

Jake Cochran,

Jenn Haynie,

Justina Ilutsik,

Cynthia Longo,

Stephanie Swint,

J. Kamile Rasheed,

Allison C. Brown,

Maria Karlsson

Publication year - 2020

Publication title -

antimicrobial agents and chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.07

H-Index - 259

eISSN - 1070-6283

pISSN - 0066-4804

DOI - 10.1128/aac.00499-20

Subject(s) - new delhi , antibiotics , bacteria , public health , microbiology and biotechnology , antibiotic resistance , carbapenem , biology , medicine , genetics , nursing , metropolitan area , pathology

The treatment of infections caused by carbapenem-resistantEnterobacterales , especially New Delhi metallo-β-lactamase (NDM)-producing bacteria, is challenging. Although less common in the United States than some other carbapenemase producers, NDM-producing bacteria are a public health threat due to the limited treatment options available. Here, we report on the antibiotic susceptibility of 275 contemporary NDM-producingEnterobacterales collected from 30 U.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research